-
1تقرير
المصدر: A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04923178Test
-
2تقرير
المساهمون: Andrea Apolo, M.D., Principal Investigator
المصدر: A Phase II Study of Bintrafusp Alfa (M7824) in Checkpoint Inhibitor Naive and Refractory Subjects With Urothelial Carcinoma
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04501094Test
-
3تقرير
المصدر: A Phase I Study of Bintrafusp Alfa (M7824) and NHS-IL12 (M9241) Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04235777Test
-
4تقرير
المصدر: A Phase I/II Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in Patients With Relapsed/Refractory Small Cell Lung, Bladder and Prostate Cancers
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT02769962Test
-
5تقرير
المساهمون: Steven Rosenberg, M.D., Principal Investigator
المصدر: Morgan RA, Dudley ME, Yu YY, Zheng Z, Robbs PF, Theoret MR, Wunderlh JR, Hughes MS, Resto NP, Rosenberg SA. Hh effncy TCR gene transfer to prary human lymphocytes affords av recognn of melanoma tumor anten glycoprote 100 and does not alter the recognn of autologous melanoma antens. J munol. 2003 Sep 15;171(6):3287-95. do 10.4049/jmunol.171.6.3287.
SurA. Cancer test antens--the portance munotherapy and the early detectn of cancer. Expert Op Bl Ther. 2006 Apr;6(4):379-89. do 10.1517/14712598.6.4.379.
Robbs PF, Morgan RA, Feldman SA, Yang JC, Sherry RM, Dudley ME, Wunderlh JR, NahvAV, Helman LJ, Mackall CL, Kammula US, Hughes MS, Resto NP, Raffeld M, Lee CC, Levy CL, LYF, El-Gam M, Schwarz SL, Laurencot C, Rosenberg SA. Tumor regressn patnts wh metastat synovl cell sarcoma and melanoma usg genetally engeered lymphocytes reacte wh NY-ESO-1. J Cl Oncol. 2011 Mar 1;29(7):917-24. do 10.1200/JCO.2010.32.2537. Epub 2011 Jan 31.
A Phase I/II Study of the Treatment of Metastatic Cancer That Expresses MAGE-A3 Using Lymphodepleting Conditioning Followed by Infusion of HLA-DP0401/0402 Restricted Anti-MAGE-A3 TCR-Gene Engineered Lymphocytes and Aldesleukinالوصول الحر: https://clinicaltrials.gov/ct2/show/NCT02111850Test
-
6تقرير
المصدر: Care of the Urothelial Cancer Patient and Prospective Collection of Biospecimens From Healthy Volunteers and Urothelial Cancer Patients
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT02379429Test